ICM
FA icon

Invenomic Capital Management’s First Advantage FA Stock Holding History

Invenomic Capital Management’s Portfolio FA Stock Details FA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-295,855
Closed -$4.75M – 155
2024
Q2 		$4.75M Buy
+295,855
New +$4.76M 0.23% 105

Other funds holding FA

SLG
Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $16B AUM 4.15% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Invenomic Capital Management's FA Position: Q3 2024 in Review

Invenomic Capital Management sold out of First Advantage (FA) in Q3 2024, closing a stake of 295,855 shares — an estimated $4.75M sold.

Invenomic Capital Management first reported a position in FA in Q2 2024 and held it in 1 quarter. The position peaked at $4.75M in Q2 2024. 127 funds tracked by Wall St. Rank hold FA as of Q3 2024.

  • Invenomic Capital Management reported no remaining First Advantage position as of Q3 2024 after selling out during the quarter.
  • Invenomic Capital Management sold 295,855 First Advantage shares in Q3 2024, an estimated $4.75M.
  • Invenomic Capital Management first reported a position in First Advantage in Q2 2024 and held it in 1 quarter.
  • Invenomic Capital Management's First Advantage position peaked at $4.75M in Q2 2024.
  • 127 funds tracked by Wall St. Rank held First Advantage as of Q3 2024.

Based on Invenomic Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.